Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021

SAN DIEGO: SAN DIEGO, July 21, 2021 /PRNewswire/ — Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on Wednesday, July 28, 2021. The company will host a conference call to discuss financial results and general corporate updates beginning at 4:30 p.m. Eastern Time on Wednesday, July 28, 2021. To participate on the conference call, please dial (844) 850-0543 from the U.S. or (412) 317-5199 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until August 4, 2021 by dialing (877) 344-7529 from the U.S. or (412) 317-0088 from outside the U.S. and entering conference ID #10157666. Those interested in listening to the conference call live via the internet may…
Click here to view original post